Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

BioCryst Pharmaceuticals, Inc. BCRX

Set alert

Price alert · BCRX

All alert types
8.35 USD +0.10 +1.21%

As of Nov 3, 10:14 AM ET

Bid
8.34 × 13
Ask
8.35 × 21
8.19 Day range 8.38
6.23 52-week range 11.22
YTD
+6.99%
1 year
+21.65%
Open
8.23
Prev close
8.25
Mkt cap
2.12B
Vol
367.46K
Avg vol
4.61M
EPS
-1.40
P/E
0.00
Div yield
0.00%
More statistics
Low
8.19
High
8.38
Forward P/E
9.99
Beta
0.51
Short ratio
4.97
Inst. own
105.87%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
8.63
200-d avg
8.75
1y target
20.55

5D chart

Chart tools
Interval
1m5m15m30m

Signals (71)
NameTimeAgo
SMA: BearishNov 2, 9:35 AM1 day ago
SMA: BullishOct 30, 3:05 PM3 days ago
SMA: BullishOct 30, 2:55 PM3 days ago
SMA: BearishOct 30, 2:40 PM3 days ago
SMA: BullishOct 30, 2:05 PM3 days ago
SMA: BullishOct 30, 1:55 PM3 days ago
MACD: Buy SignalOct 30, 1:55 PM3 days ago
MACD: Sell SignalOct 30, 12:45 PM3 days ago
SMA: BearishOct 30, 12:30 PM3 days ago
MACD: Buy SignalOct 30, 12:15 PM3 days ago
MACD: Sell SignalOct 30, 11:35 AM3 days ago
SMA: BearishOct 30, 11:20 AM3 days ago
SMA: BullishOct 30, 11:15 AM3 days ago
SMA: BearishOct 30, 11:10 AM4 days ago
MACD: Buy SignalOct 30, 10:55 AM4 days ago
SMA: BullishOct 30, 10:40 AM4 days ago
SMA: BearishOct 30, 10:00 AM4 days ago
MACD: Sell SignalOct 30, 9:55 AM4 days ago
RSI: OverboughtOct 30, 9:30 AM4 days ago
SMA: BullishOct 29, 3:55 PM4 days ago

Newest 20 of 71.

Analyst view

Consensus: buy

Buy
Price target (mean) 20.55 +146.2% upside
Target (low)
11.00
Target (mean)
20.55
Target (high)
32.00
Ratings (0m) 11 9 buy · 2 hold · 0 sell
  • Strong buy2
  • Buy7
  • Hold2
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 11
  • 1 month ago 11
  • 2 months ago 11

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

BCRX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.1150.10 – 0.130.16-28.1%165.68M+3.9%2
Next quarter0.130.11 – 0.150.2083-37.6%169.77M-58.2%2
Current year0.750.70 – 0.800.6347+18.2%710.08M-18.8%2
Next year0.8250.80 – 0.850.75+10.0%736.43M+3.7%2

Upgrades and downgrades

The latest rating changes

BCRX analyst upgrades and downgrades
DateFirmActionFromTo
Sep 30, 2026JP MorganMaintainedNeutralNeutral
Sep 10, 2026RBC CapitalDowngradeOutperformSector Perform
Sep 8, 2026NeedhamReiteratedBuyBuy
Aug 6, 2026RBC CapitalMaintainedOutperformOutperform
Aug 6, 2026WedbushMaintainedOutperformOutperform
Jul 7, 2026RBC CapitalMaintainedOutperformOutperform
Jun 30, 2026HC Wainwright & Co.MaintainedBuyBuy
Jun 30, 2026Cantor FitzgeraldMaintainedOverweightOverweight
May 7, 2026CitizensMaintainedMarket OutperformMarket Outperform
May 7, 2026WedbushMaintainedOutperformOutperform
May 6, 2026NeedhamMaintainedBuyBuy
Jan 30, 2026RBC CapitalMaintainedOutperformOutperform
Dec 15, 2025HC Wainwright & Co.MaintainedBuyBuy
Nov 5, 2025CitizensMaintainedMarket OutperformMarket Outperform
Nov 4, 2025BarclaysMaintainedEqual-WeightEqual-Weight
Nov 4, 2025NeedhamMaintainedBuyBuy
Oct 15, 2025Cantor FitzgeraldMaintainedOverweightOverweight
Oct 15, 2025JMP SecuritiesMaintainedMarket OutperformMarket Outperform
Oct 15, 2025NeedhamMaintainedBuyBuy
Aug 4, 2025NeedhamMaintainedBuyBuy
Jul 1, 2025B of A SecuritiesMaintainedBuyBuy
Jun 30, 2025RBC CapitalReiteratedOutperformOutperform
Jun 30, 2025WedbushMaintainedOutperformOutperform
Jun 27, 2025NeedhamReiteratedBuyBuy
Jun 25, 2025NeedhamReiteratedBuyBuy
May 7, 2025BarclaysMaintainedEqual-WeightEqual-Weight
May 6, 2025RBC CapitalReiteratedOutperformOutperform
May 6, 2025JP MorganMaintainedOverweightOverweight
May 6, 2025HC Wainwright & Co.ReiteratedBuyBuy
May 6, 2025NeedhamMaintainedBuyBuy